Copyright
©The Author(s) 2025.
World J Psychiatry. Aug 19, 2025; 15(8): 108933
Published online Aug 19, 2025. doi: 10.5498/wjp.v15.i8.108933
Published online Aug 19, 2025. doi: 10.5498/wjp.v15.i8.108933
Table 3 Summary of changes of exosomal microRNAs in schizophrenia related animal experiments
miRNAs | Alteration | Model | Type tissue | Significance | Ref. |
miR-137 | Increase | Gclm-KO mice, human patients | Plasma, prefrontal cortex | The changes in the level of miR-137/COX6A2 in plasma exosomes may be a marker of schizophrenia caused by PVI injury resulting from mitochondrial oxidative stress | Khadimallah et al[49] |
miR-146a-5p | Increase | Schizophrenia mouse models, cell models | Plasma, cell | It may target NOTCH1, inhibit synaptic activity mediated by the Notch signaling pathway, and ultimately promote the occurrence and progression of schizophrenia in mice | Wang et al[89] |
miR-223-3p | Increase | Mouse models, human postmortem brain, cell models | Cortical neuron, postmortem brain, astrocyte | miR-223 is a miRNA secreted by exosomes targeting glutamate receptors | Amoah et al[90] |
- Citation: He YN, Zhu HH, Zhou ZH, Qu KK. Exosomal microRNAs in common mental disorders: Mechanisms, biomarker potential and therapeutic implications. World J Psychiatry 2025; 15(8): 108933
- URL: https://www.wjgnet.com/2220-3206/full/v15/i8/108933.htm
- DOI: https://dx.doi.org/10.5498/wjp.v15.i8.108933